Renal Safety Evaluation After Dotarem®-Enhanced MRI

PHASE4CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2011

Study Completion Date

August 31, 2011

Conditions
Renal Insufficiency
Interventions
DRUG

Dotarem®-enhanced MRI

Single IV administration before MRI exam

OTHER

non-enhanced MRI

non injected MRI

Trial Locations (15)

8800

Alg. Inwendige Ziekten -Nierziekten, Roeselare

9000

University Hospital Ghent, Ghent

9300

Onze Lievevrouwziekenhuis, Aalst

16128

Ente Ospedaliero Ospedali Galliera,, Genova

28040

Hospital San Carlos, Madrid

33076

Groupe Hospitalier Pellegrin, Bordeaux

37044

Hôpital Trousseau, Tours

44100

Azienda Ospedaliera Universitaria di Ferrara, Ferrara

46017

Hospital Dr PESET, Valencia

59037

Hôpital A. Calmette, Lille

67000

CHU Strasbourg, Strasbourg

69437

Hôpital Edouard Herriot, Lyon

75013

Hopital Pitie Salpetriere, Paris

75018

Hopital Bichat, Paris

75020

Hôpital Tenon, Paris

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Guerbet

INDUSTRY